Uncategorized
Geographic Atrophy: Clinical Impact and Emerging Treatments
Geographic atrophy remains an important cause of permanent vision loss despite historic progress made in managing vitreoretinal diseases over the past decade. Fortunately, our understanding of age-related macular degeneration pathophysiology has reached a level that has allowed us to embark on several clinical trials to discover treatments to manage this difficult disease. Availability of animal models and advances in imaging (OCT and autofluorescence) have aided in the possibility of upcoming breakthrough treatments for GA.